Evidence map›Paper›PMID 40408421›Full record

Observational studyPloS one2025

Mortality rates in a cohort of infants attending immunization clinics in Uganda (2017-2019).

Samuel Sendagala, Rose Bosa Nakityo, Fredrick Makumbi, Tom Lutalo, Linda Nabitaka, Fred Nalugoda, Ivan Lukabwe, Jingo Kasule, Emily Namara-Lugolobi, Margaret Achom Okwero and 5 more

Abstract readObservational Study
In one paragraph

Observational study in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Samuel SendagalaUS Centers for Disease Control and Prevention, Global Health Center, Division of Global HIV and TB, Kampala, Uganda.ORCID https://orcid.org/0000-0002-3981-7953
Rose Bosa NakityoUS Centers for Disease Control and Prevention, Global Health Center, Division of Global HIV and TB, Kampala, Uganda.ORCID https://orcid.org/0000-0002-8211-7012
Fredrick MakumbiData and Statistics Department, Rakai Health Sciences Program, Kalisizo, Uganda.
Tom LutaloData and Statistics Department, Rakai Health Sciences Program, Kalisizo, Uganda.
Linda NabitakaSTI/AIDS Control Program, Department of National Disease Control, Ministry of Health, Kampala, Uganda.
Fred NalugodaData and Statistics Department, Rakai Health Sciences Program, Kalisizo, Uganda.
Ivan LukabweSTI/AIDS Control Program, Department of National Disease Control, Ministry of Health, Kampala, Uganda.
Jingo KasuleData and Statistics Department, Rakai Health Sciences Program, Kalisizo, Uganda.
Emily Namara-LugolobiUS Centers for Disease Control and Prevention, Global Health Center, Division of Global HIV and TB, Kampala, Uganda.
Margaret Achom OkweroUS Centers for Disease Control and Prevention, Global Health Center, Division of Global HIV and TB, Kampala, Uganda.
Hilda T AsiimweUnited States Agency for International Development, Kampala, Uganda.
Phoebe NamukanjaUS Centers for Disease Control and Prevention, Global Health Center, Division of Global HIV and TB, Kampala, Uganda.
Bernadette Ng'enoUS Centers for Disease Control and Prevention, Global Health Center, Division of Global HIV and TB, Atlanta, Georgia, United States of America.
Emilio DirlikovUS Centers for Disease Control and Prevention, Global Health Center, Division of Global HIV and TB, Kampala, Uganda.ORCID https://orcid.org/0000-0003-4631-2643
Augustina DelaneyUS Centers for Disease Control and Prevention, Global Health Center, Division of Global HIV and TB, Atlanta, Georgia, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUganda reported a significant reduction in the mortality rate of children under 5 years of age, from 146/1,000 live births in 2000-42/1,000 live births in 2021. With the rollout of Option B+, the vertical transmission rate of HIV decreased from 13.0% (2012) to 6.0% (2019). However, its impact on the mortality rate among children is not well documented. We determined the mortality rate and associated risk factors among infants exposed and not exposed to HIV attending immunization clinics in Uganda.

methodsWe conducted an observational prospective cohort study of mother-infant pairs (MIPs) with infants exposed or unexposed to HIV. We enrolled infants aged 4-12 weeks. The inclusion criteria were biological mothers attending health facilities that provide routine immunization for children and/or postnatal care visits who were able to provide signed written informed consent; mothers or infants who were not severely ill; and those who consented to have their infants tested for HIV antibodies at baseline and follow-up visits every 3 months until the children were aged 18 months. Child-HIV infection and death were censored events. Children lost to follow-up or withdrawn from the study were censored from analyses at the last documented study visit. The outcome of interest was child mortality, and the independent variables were mother's age; infant HIV exposure status; infant sex; family socioeconomic status; marital status; education level; malaria during pregnancy; birth attendee; mother's ART initiation; mode of transport to health facilities; breastfeeding pattern; 4 or more ANC visits; and mother's baseline viral load nonsuppression and place of delivery. We used Kaplan-Meier survival curves to estimate cumulative mortality probability and the Wilcoxon log-rank test to compare differences in cumulative survival functions. We used multivariate Weibull proportional hazards and Weibull accelerated failure time (AFT) regression models with 95% confidence intervals (CIs) to identify factors associated with child death.

resultsAmong the 16,718 MIPs identified, 11,519 (68.9%) mothers consented to study follow-up. At the 18-month follow-up, 0.7% (79/11,519) of the infants had died, 40.5% (32/79) of whom were exposed to HIV. The overall child mortality rate per 1,000 person-years was 5.0 (95% CI: 4.0--6.2) and was significantly greater among the infants exposed to HIV (14.2; 95% CI: 10.0--20.0) than among the infants not exposed to HIV (3.5; 95% CI: 2.6--4.6). In the adjusted model, the mortality risk factors were HIV exposure status (aHR5.6 95% CI: 3.5--9.4), maternal age < 25 years (aHR1.8; 95% CI: 1.1--2.9), living without a partner (aHR1.8; 95% CI: 1.1--2.9), and delivery at home (aHR2.2; 95% CI: 1.3--4.0).

conclusionSingle young mothers living with HIV delivering at home increased the risk of child mortality. Identifying mothers with risk factors early for support could reduce the risk of child mortality.

Indexed as

HIV InfectionsImmunizationInfant MortalityInfectious Disease Transmission, VerticalAdultCohort StudiesFemaleHumansInfantInfant, NewbornMalePregnancyProspective StudiesRisk FactorsUganda

Identifiers

PMID40408421
PMCPMC12101647

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.